MRC1 and Stroke: Conversely, analysis of Iba-1 and CD206 demonstrated a significant decrease in CD206+/Iba-1+ cells in the Stroke group compared to Sham controls, indicating a shift away from an anti-inflammatory phenotype (p < 0.001) (Figure 2(A,B)).